Basement membrane proteoglycans: from cellar to ceiling (original) (raw)

• Yurchenco, P. D., Amenta, P. S. & Patton, B. L. Basement membrane assembly, stability and activities observed through a developmental lens. Matrix Biol. 22, 521–538 (2004). An excellent and comprehensive review on basement membrane constituents.
  Article CAS PubMed Google Scholar
• Kanwar, Y. S. & Farquhar, M. G. Presence of heparan sulfate in the glomerular basement membrane. Proc. Natl Acad. Sci. USA 76, 1303–1307 (1979).
  Article CAS PubMed PubMed Central Google Scholar
• Oh, S. P. et al. Isolation and sequencing of cDNAs for proteins with multiple domains of Gly-Xaa-Yaa repeats identify a distinct family of collagenous proteins. Proc. Natl Acad. Sci. USA 91, 4229–4233 (1994).
  Article CAS PubMed PubMed Central Google Scholar
• Rehn, M. & Pihlajaniemi, T. α1(XVIII), a collagen chain with frequent interruptions in the collagenous sequence, a distinct tissue distribution, and homology with type XV collagen. Proc. Natl Acad. Sci. USA 91, 4234–4238 (1994). References 3 and 4 provide the first reports on collagen XVIII.
  Article CAS PubMed PubMed Central Google Scholar
• Iozzo, R. V. Matrix proteoglycans: from molecular design to cellular function. Annu. Rev. Biochem. 67, 609–652 (1998).
  Article CAS PubMed Google Scholar
• Bezakova, G. & Ruegg, M. A. New insights into the roles of agrin. Nature Rev. Mol. Cell Biol. 4, 295–308 (2003).
  Article CAS Google Scholar
• Iozzo, R. V. & San Antonio, J. D. Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena. J. Clin. Invest. 108, 349–355 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Li, D., Clark, C. C. & Myers, J. C. Basement membrane zone type XV collagen is a disulfide-bonded chondroitin sulfate proteoglycan in human tissues and cultured cells. J. Biol. Chem. 275, 22339–22347 (2000).
  Article CAS PubMed Google Scholar
• Marneros, A. G. & Olsen, B. R. The role of collagen-derived proteolytic fragments in angiogenesis. Matrix Biol. 20, 337–345 (2001).
  Article CAS PubMed Google Scholar
• Saarela, J., Rehn, M., Oikarinen, A., Autio-Harmainen, H. & Pihlajaniemi, T. The short and long forms of type XVIII collagen show clear tissue specificities in their expression and location in basement membrane zones in humans. Am. J. Pathol. 153, 611–626 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Muragaki, Y. et al. Mouse Col18a1 is expressed in a tissue-specific manner as three alternative variants and is localized in basement membrane zones. Proc. Natl Acad. Sci. USA 92, 8763–8767 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Rehn, M. & Pihlajaniemi, T. Identification of three N-terminal ends of type XVIII collagen chains and tissue-specific differences in the expression of the corresponding transcripts. The longest form contains a novel motif homologous to rat and Drosophila frizzled proteins. J. Biol. Chem. 270, 4705–4711 (1995).
  Article CAS PubMed Google Scholar
• Halfter, W., Dong, S., Schurer, B. & Cole, G. J. Collagen XVIII is a basement membrane heparan sulfate proteoglycan. J. Biol. Chem. 273, 25404–25412 (1998). These authors discovered that collagen XVIII is a heparan sulphate proteoglycan.
  Article CAS PubMed Google Scholar
• Dong, G, Cole, G. J. & Halfter, W. Expression of collagen XVIII and localization of its glycosaminoglycan attachment sites. J. Biol. Chem. 278, 1700–1707 (2003).
  Article CAS PubMed Google Scholar
• Pufe, T. et al. Endostatin/collagen XVIII — an inhibitor of angiogenesis — is expressed in cartilage and fibrocartilage. Matrix Biol. 23, 267–276 (2004).
  Article CAS PubMed Google Scholar
• Amenta, P. S. et al. Proteoglycan-collagen XV in human tissues is seen linking banded collagen fibers subjacent to the basement membrane. J. Histochem. Cytochem. 53, 165–176 (2005).
  Article CAS PubMed Google Scholar
• Fukai, N. et al. Lack of collagen XVIII/endostatin results in eye abnormalities. EMBO J. 21, 1535–1544 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Ylikärppä, R. et al. Lack of type XVIII collagen results in anterior ocular defects. FASEB J. 17, 2257–2259 (2003). By generating collagen-XVIII-null animals, these authors (references 17 and 18) provide compelling evidence for a principal role of collagen XVIII in eye development.
  Article PubMed CAS Google Scholar
• Marneros, A. G. et al. Collagen XVIII/endostatin is essential for vision and retinal pigment epithelial function. EMBO J. 23, 89–99 (2004).
  Article CAS PubMed Google Scholar
• Sertie, A. L. et al. Collagen XVIII, containing an endogenous inhibitor of angiogenesis and tumor growth, plays a critical role in the maintenance of retinal structure and in neural tube closure (Knobloch syndrome). Human Mol. Gen. 9, 2051–2058 (2000).
  Article CAS Google Scholar
• Suzuki, O. T. et al. Molecular analysis of collagen XVIII reveals novel mutations, presence of a third isoform, and possible genetic heterogeneity in Knobloch syndrome. Am. J. Hum. Genet. 71, 1320–1329 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Utriainen, A. et al. Structurally altered basement membranes and hydrocephalus in a type XVIII collagen deficient mouse line. Human Mol. Gen. 13, 2089–2099 (2004).
  Article CAS Google Scholar
• Moulton, K. S. et al. Loss of collagen XVIII enhances neovascularization and vascular permeability in atherosclerosis. Circulation 110, 1330–1336 (2004).
  Article CAS PubMed Google Scholar
• Elamaa, H., Sormunen, R., Rehn, M., Soininen, R. & Pihlajaniemi, T. Endostatin overexpression specifically in the lens and skin leads to cataract and ultrastructural alterations in basement membranes. Am. J. Pathol. 166, 221–229 (2004).
  Article Google Scholar
• Ackley, B. D. et al. The NC1/endostatin domain of Caenorhabditis elegans type XVIII collagen affects cell migration and axon guidance. J. Cell Biol. 152, 1219–1232 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Kliemann, S. E., Waetge, R. T., Suzuki, O. T., Passos-Bueno, M. R. & Rosemberg, S. Evidence of neuronal migration disorders in Knobloch syndrome: clinical and molecular analysis of two novel families. Am. J. Med. Genet. 119, 15–19 (2003).
  Article Google Scholar
• Ackley, B. D. et al. The basement membrane components nidogen and type XVIII collagen regulate organization of neuromuscular junctions in Caenorhabditis elegans. J. Neurosci. 23, 3577–3587 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Eklund, L. et al. Lack of type XV collagen causes a skeletal myopathy and cardiovascular defects in mice. Proc. Natl Acad. Sci. USA 98, 1194–1199 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Ylikärppä, R. et al. Double knockout mice reveal a lack of major functional compensation between collagens XV and XVIII. Matrix Biol. 22, 443–448 (2003).
  Article PubMed CAS Google Scholar
• Noonan, D. M. et al. The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipoprotein-receptor, and the neural cell adhesion molecule. J. Biol. Chem. 266, 22939–22947 (1991). The first complete characterization of the modular nature of perlecan protein core.
  Article CAS PubMed Google Scholar
• Iozzo, R. V. Perlecan: a gem of a proteoglycan. Matrix Biol. 14, 203–208 (1994).
  Article CAS PubMed Google Scholar
• Iozzo, R. V., Cohen, I. R., Grä ssel, S. & Murdoch, A. D. The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices. Biochem. J. 302, 625–639 (1994).
  Article CAS PubMed PubMed Central Google Scholar
• Dolan, M., Horchar, T., Rigatti, B. & Hassell, J. R. Identification of sites in domain I of perlecan that regulate heparan sulfate synthesis. J. Biol. Chem. 272, 4316–4322 (1997).
  Article CAS PubMed Google Scholar
• Friedrich, M. V. K. et al. Structural basis of glycosaminoglycan modification and of heterotypic interactions of perlecan domain V. J. Mol. Biol. 294, 259–270 (1999).
  Article CAS PubMed Google Scholar
• Rogalski, T. M., Williams, B. D., Mullen, G. P. & Moerman, D. G. Products of the unc-52 gene in Caenorhabditis elegans are homologous to the core protein of the mammalian basement membrane heparan sulfate proteoglycan. Genes Dev. 7, 1471–1484 (1993).
  Article CAS PubMed Google Scholar
• Cohen, I. R., Grä ssel, S., Murdoch, A. D. & Iozzo, R. V. Structural characterization of the complete human perlecan gene and its promoter. Proc. Natl Acad. Sci. USA 90, 10404–10408 (1993).
  Article CAS PubMed PubMed Central Google Scholar
• Friedrich, M. V. K., Schneider, M., Timpl, R. & Baumgartner, S. Perlecan domain V of Drosophila melanogaster – sequence, recombinant analysis and tissue expression. Eur. J. Biochem. 267, 3149–3159 (2000).
  Article CAS PubMed Google Scholar
• Iozzo, R. V. Biosynthesis of heparan sulfate proteoglycan by human colon carcinoma cells and its localization at the cell surface. J. Cell Biol. 99, 403–417 (1984).
  Article CAS PubMed Google Scholar
• Bix, G. & Iozzo, R. V. Matrix revolutions: 'tails' of basement-membrane components with angiostatic functions. Trends Cell Biol. 15, 52–60 (2005).
  Article CAS PubMed Google Scholar
• SundarRaj, N., Fite, D., Ledbetter, S., Chakravarti, S. & Hassell, J. R. Perlecan is a component of cartilage matrix and promotes chondrocyte attachment. J. Cell Sci. 108, 2663–2672 (1995).
  Article CAS PubMed Google Scholar
• Handler, M., Yurchenco, P. D. & Iozzo, R. V. Developmental expression of perlecan during murine embryogenesis. Dev. Dyn. 210, 130–145 (1997). Comprehensive analysis of perlecan expression in murine development.
  Article CAS PubMed Google Scholar
• French, M. M. et al. Expression of the heparan sulfate proteoglycan, perlecan, during mouse embryogenesis and perlecan chondrogenic activity in vitro. J. Cell Biol. 145, 1103–1115 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Melrose, J., Smith, S. & Whitelock, J. Perlecan immunolocalizes to perichondrial vessels and canals in human fetal cartilaginous primordia in early vascular and matrix remodeling events associated with diarthrodial joint development. J. Histochem. Cytochem. 52, 1405–1413 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Govindraj, P. et al. Isolation and identification of the major heparan sulfate proteoglycans in the developing bovine rib growth plate. J. Biol. Chem. 277, 19461–19469 (2002).
  Article CAS PubMed Google Scholar
• Iozzo, R. V. & Murdoch, A. D. Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function. FASEB J. 10, 598–614 (1996).
  Article CAS PubMed Google Scholar
• Nugent, M. A., Nugent, H. M., Iozzo, R. V., Sanchack, K. & Edelman, E. R. Perlecan is required to inhibit thrombosis after deep vascular injury and contributes to endothelial cell-mediated inhibition of intimal hyperplasia. Proc. Natl Acad. Sci. USA 97, 6722–6727 (2000). Presents compelling evidence for a role of perlecan in vascular injury.
  Article CAS PubMed PubMed Central Google Scholar
• Tapanadechopone, P., Tumova, S., Jiang, X. & Couchman, J. R. Epidermal transformation leads to increased perlecan synthesis with heparin-binding-growth-factor affinity. Biochem. J. 355, 517–527 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Jiang, J. et al. Essential contribution of tumor-derived perlecan to epidermal tumor growth and angiogenesis. J. Histochem. Cytochem. 52, 1575–1590 (2004).
  Article CAS PubMed Google Scholar
• Hassell, J. R., Yamada, Y. & Arikawa-Hirasawa, E. Role of perlecan in skeletal development and diseases. Glycoconj. J. 19, 263–267 (2003).
  Article Google Scholar
• Olsen, B. R. Life without perlecan has its problems. J. Cell Biol. 147, 909–911 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Costell, M. et al. Perlecan maintains the integrity of cartilage and some basement membranes. J. Cell Biol. 147, 1109–1122 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Arikawa-Hirasawa, E., Watanabe, E., Takami, H., Hassell, J. R. & Yamada, Y. Perlecan is essential for cartilage and cephalic development. Nature Genet. 23, 354–358 (1999). References 51 and 52 report the first characterization of perlecan-deficient mice and describe multiple vascular and cartilage abnormalities.
  Article CAS PubMed Google Scholar
• Costell, M. et al. Hyperplastic conotruncal endocardial cushions and transposition of great arteries in perlecan-null mice. Circ. Res. 91, 158–164 (2002).
  Article CAS PubMed Google Scholar
• González-Iriarte, M. et al. Development of the coronary arteries in a murine model of transposition of great arteries. J. Mol. Cell. Cardio. 35, 795–802 (2003).
  Article CAS Google Scholar
• Rossi, M. et al. Heparan sulfate chains of perlecan are indispensable in the lens capsule but not in the kidney. EMBO J. 22, 236–245 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Tran, P. -K. et al. Increased intimal hyperplasia and smooth muscle cell proliferation in transgenic mice with heparan sulfate-deficient perlecan. Circ. Res. 94, 550–558 (2004).
  Article CAS PubMed Google Scholar
• Zhou, Z. et al. Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice. Cancer Res. 64, 4699–4702 (2004). The phenotype of perlecan-null mice is indeed complex, as shown by additional characterization of perlecan-deficient animals (references 53 and 54), or transgenic animals in which the heparan sulphate chains of perlecan were specifically targeted (references 55–57).
  Article CAS PubMed Google Scholar
• Arikawa-Hirasawa, E. et al. Dyssegmental dysplasia, Silverman–Handmaker type, is caused by functional null mutations of the perlecan gene. Nature Genet. 27, 431–434 (2001).
  Article CAS PubMed Google Scholar
• Arikawa-Hirasawa, E., Wilcox, W. R. & Yamada, Y. Dyssegmental dysplasia, Silverman–Handmaker type: unexpected role of perlecan in cartilage development. Am. J. Med. Genet. 106, 254–257 (2001).
  Article CAS PubMed Google Scholar
• Nicole, S. et al. Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz–Jampel syndrome (chondrodystrophic myotonia). Nature Genet. 26, 480–483 (2000).
  Article CAS PubMed Google Scholar
• Arikawa-Hirasawa, E. et al. Structural and functional mutations of the perlecan gene cause Schwartz–Jampel syndrome, with myotonic myopathy and chondrodysplasia. Am. J. Hum. Genet. 70, 1368–1375 (2002). References 58–61 show a direct involvement of perlecan gene mutations in causing two distinct human genetic syndromes.
  Article CAS PubMed PubMed Central Google Scholar
• Cartaud, A. et al. MuSK is required for anchoring acetylcholinesterase at the neuromuscular junction. J. Cell Biol. 165, 505–515 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Arikawa-Hirasawa, E., Rossi, S. G., Rotundo, R. L. & Yamada, Y. Absence of acetylcholinesterase at the neuromuscular junctions of perlecan-null mice. Nature Neurosci. 5, 119–123 (2002).
  Article CAS PubMed Google Scholar
• Voigt, A., Pflanz, R., Schafer, U. & Jackle, H. Perlecan participates in proliferation activation of quiescent Drosophila neuroblasts. Dev. Dyn. 224, 403–412 (2002).
  Article CAS PubMed Google Scholar
• Park, Y. et al. Drosophila perlecan modulates FGF and hedgehog signals to activate neural stem cell division. Dev. Biol. 253, 247–257 (2003). Shows that perlecan is directly involved in modulating growth factors and morphogens during development.
  Article CAS PubMed Google Scholar
• Rogalski, T. M., Gilchrist, E. J., Mullen, G. P. & Moerman, D. G. Mutations in the unc-52 gene responsible for body wall muscle defects in adult Caenorhabditis elegans are located in alternatively spliced exons. Genetics 139, 159–169 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Mullen, G. P., Rogalski, T. M., Bush, J. A., Gorji, P. R. & Moerman, D. G. Complex patterns of alternative splicing mediate the spatial and temporal distribution of perlecan/UNC-52 in Caenorhabditis elegans. Mol. Biol. Cell 10, 3205–3221 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Merz, D. C., Alves, G., Kawano, T., Zheng, H. & Culotti, J. G. UNC-52/perlecan affects gonadal leader cell migrations in C. elegans hermaphrodites through alterations in growth factor signaling. Dev. Biol. 256, 173–186 (2003).
  Article CAS PubMed Google Scholar
• O'Reilly, M. S. et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88, 277–285 (1997).
  Article CAS PubMed Google Scholar
• Hohenester, E., Sasaki, T., Olsen, B. R. & Timpl, R. Crystal structure of the angiogenesis inhibitor endostatin at 1.5 Å resolution. EMBO J. 17, 1656–1664 (1998). An important paper that reports the solution structure of the C-terminal end of collagen XVIII, endostatin.
  Article CAS PubMed PubMed Central Google Scholar
• Sasaki, T. et al. Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin. EMBO J. 18, 6240–6248 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Kreuger, J. et al. Role of heparan sulfate domain organization in endostatin inhibition of endothelial cell function. EMBO J. 21, 6303–6311 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Boehm, T., Folkman, J., Browder, T. & O'Reilly, M. S. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 390, 404–407 (1997).
  Article CAS PubMed Google Scholar
• Sasaki, T. et al. Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin. EMBO J. 17, 4249–4256 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Yamaguchi, N. et al. Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. EMBO J. 18, 4414–4423 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Citrin, D. et al. In vivo tumor imaging in mice with near-infrared labeled endostatin. Mol. Can. Ther. 3, 481–488 (2004). Reports clear evidence that endostatin targets the tumour vasculature.
  CAS Google Scholar
• Ramchandran, R. et al. Antiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin. Biochem. Biophys. Res. Commun. 255, 735–739 (1999).
  Article CAS PubMed Google Scholar
• Sasaki, T. et al. Endostatins derived from collagens XV and XVIII differ in structural and binding properties, tissue distribution and anti-angiogenic activity. J. Mol. Biol. 301, 1179–1190 (2000).
  Article CAS PubMed Google Scholar
• Bilbe, G. et al. Restin: a novel intermediate filament-associated protein highly expressed in the Reed–Sternberg cells of Hodgkin's disease. EMBO J. 11, 2103–2113 (1992).
  Article CAS PubMed PubMed Central Google Scholar
• Gaetzner, S. et al. Endostatin's heparan sulfate-binding site is essential for inhibition of angiogenesis and enhances in situ binding to capillary-like structures in bone explants. Matrix Biol. 23, 557–561 (2005).
  Article CAS PubMed Google Scholar
• Mongiat, M., Sweeney, S., San Antonio, J. D., Fu, J. & Iozzo, R. V. Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan. J. Biol. Chem. 278, 4238–4249 (2003). The first report of endorepellin as an angiostatic factor.
  Article CAS PubMed Google Scholar
• Bix, G. et al. Endoprepellin causes endothelial cell disassembly of actin cytoskeleton and focal adhesions through the α2β1 integrin. J. Cell Biol. 166, 97–109 (2004). This paper addresses the mechanism of action of endorepellin.
  Article CAS PubMed PubMed Central Google Scholar
• Miosge, N., Simniok, T., Sprysch, P. & Herken, R. The collagen type XVIII endostatin domain is co-localized with perlecan in basement membranes in vivo. J. Histochem. Cytochem. 51, 285–296 (2003).
  Article CAS PubMed Google Scholar
• Gonzalez, E. M. et al. BMP-1/Tolloid-like metalloproteases process endorepellin, the angiostatic C-terminal fragment of perlecan. J. Biol. Chem. 280, 7080–7087 (2005).
  Article CAS PubMed Google Scholar
• Hohenester, E., Tisi, D., Talts, J. F. & Timpl, R. The crystal structure of a laminin G-like module reveals the molecular basis of α-dystroglycan binding to laminins, perlecan, and agrin. Mol. Cell 4, 783–792 (1999).
  Article CAS PubMed Google Scholar
• Tisi, D., Talts, J. F., Timpl, R. & Hohenester, E. Structure of the C-terminal laminin G-like domain pair of the laminin α2 chain harbouring binding sites for α-dystroglycan and heparin. EMBO J. 19, 1432–1440 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Wizemann, H. et al. Distinct requirements for heparin and α-dystroglycan binding revealed by structure-based mutagenesis of the laminin α2 LG4–LG5 domain pair. J. Mol. Biol. 332, 635–642 (2003).
  Article CAS PubMed Google Scholar
• Rudenko, G., Hohenester, E. & Muller, Y. A. LG/LNS domains: multiple functions — one business end? Trends Biochem. Sci. 26, 363–368 (2001).
  Article CAS PubMed Google Scholar
• Oda, O. et al. Purification and characterization of perlecan fragment in urine of end-stage renal failure patients. Clin. Chim. Acta 255, 119–132 (1996).
  Article CAS PubMed Google Scholar
• Vuadens, F. et al. Identification of biologic markers of the premature rupture of fetal membranes: proteomic approach. Proteomics 3, 1521–1525 (2003).
  Article CAS PubMed Google Scholar
• Adkins, J. N. et al. Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry. Mol. Cell. Proteom. 1, 947–955 (2002).
  Article CAS Google Scholar
• Karumanchi, S. A. et al. Cell surface glypicans are low-affinity endostatin receptors. Mol. Cell 7, 811–822 (2001).
  Article CAS PubMed Google Scholar
• Ortega, N. & Werb, Z. New functional roles for non-collagenous domains of basement membrane collagens. J. Cell Sci. 115, 4201–4214 (2002).
  Article CAS PubMed Google Scholar
• Sottile, J. Regulation of angiogenesis by extracellular matrix. Biochim. Biophys. Acta 1654, 13–22 (2004).
  CAS PubMed Google Scholar
• Rehn, M. et al. Interaction of endostatin with integrins implicated in angiogenesis. Proc. Natl Acad. Sci. USA 98, 1024–1029 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Wickström, S. A., Alitalo, K. & Keski-Oja, J. Endostatin associates with integrin α5β1 and caveolin-1, and activates Src via a tyrosyl phosphatase-dependent pathway in human endothelial cells. Cancer Res. 62, 5580–5589 (2002).
  PubMed Google Scholar
• Wickström, S. A., Alitalo, K. & Keski-Oja, J. Endostatin associates with lipid rafts and induces reorganization of the actin cytoskeleton via down-regulation of RhoA activity. J. Biol. Chem. 278, 37895–37901 (2003). References 96 and 97 provide convincing evidence for the binding of endostatin to α 5 β 1 integrin and elucidate its mechanism of action.
  Article PubMed Google Scholar
• Sudhakar, A. et al. Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by αvβ3 and α5β1 integrins. Proc. Natl Acad. Sci. USA 100, 4766–4771 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Guo, W. & Giancotti, F. G. Integrin signalling during tumour progression. Nature Rev. Mol. Cell Biol. 5, 816–826 (2004). Excellent review on integrin signalling and cancer.
  Article CAS Google Scholar
• Abdollahi, A. H. P. et al. Endostatin's antioangiogenic signaling network. Mol. Cell 13, 649–663 (2004).
  Article CAS PubMed Google Scholar
• Emsley, J., Knight, C. G., Farndale, R. W., Barnes, M. J. & Liddington, R. C. Structural basis of collagen recognition by integrin α2β1 . Cell 101, 47–56 (2000).
  Article CAS PubMed Google Scholar
• Whelan, M. C. & Senger, D. R. Collagen I initiates endothelial cell morphogenesis by inducing actin polymerization through suppression of cyclic AMP and protein kinase A. J. Biol. Chem. 278, 327–334 (2003).
  Article CAS PubMed Google Scholar
• Sweeney, S. M. et al. Angiogenesis in collagen I requires α2β1 ligation of a GFP*GER sequence and possible p38 MAPK activation and focal adhesion disassembly. J. Biol. Chem. 278, 30516–30524 (2003). References 102 and 103 investigate the role of collagen in inducing vascular morphogenesis.
  Article CAS PubMed Google Scholar
• Keezer, S. M. et al. Angiogenesis inhibitors target the endothelial cell cytoskeleton through altered regulation of heat shock protein 27 and cofilin. Cancer Res. 63, 6405–6412 (2003).
  CAS PubMed Google Scholar
• Guex, N. & Peitsch, M. C. SWISS-MODEL and Swiss-Pdb Viewer: An environment for comparative protein modeling. Electrophoresis 18, 2714–2723 (1997).
  Article CAS PubMed Google Scholar
• Aricescu, A. R., McKinnell, I. W., Halfter, W. & Stoker, A. W. Heparan sulfate proteoglycans are ligands for receptor protein tyrosine phosphatase σ. Mol. Cell Biol. 22, 1881–1892 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• van Horssen, J. et al. Collagen XVIII: a novel heparan sulfate proteoglycan associated with vascular amyloid depositions and senile plaques in Alzheimer's disease brains. Brain Pathol. 12, 456–462 (2002).
  Article CAS PubMed Google Scholar
• Bengtsson, E. et al. The leucine-rich repeat protein PRELP binds perlecan and collagens and may function as a basement membrane anchor. J. Biol. Chem. 277, 15061–15068 (2002).
  Article CAS PubMed Google Scholar
• Knox, S., Merry, C., Stringer, S., Melrose, J. & Whitelock, J. Not all perlecans are created equal. Interactions with fibroblast growth factor (FGF) 2 and FGF receptors. J. Biol. Chem. 277, 14657–14665 (2002).
  Article CAS PubMed Google Scholar
• Xu, Y., Liu, Y. J. & Yu, Q. Angiopoietin-3 is tethered on the cell surface via heparan sulfate proteoglycans. J. Biol. Chem. 279, 41179–41188 (2004).
  Article CAS PubMed Google Scholar
• Tiedemann, K. et al. Microfibrils at basement membrane zones interact with perlecan via fibrillin-1. J. Biol. Chem. 280, 11404–11412 (2005).
  Article CAS PubMed Google Scholar
• Hummel, S. et al. Extracellular matrices of the avian ovarian follicle. Molecular characterization of chicken perlecan. J. Biol. Chem. 279, 23486–23494 (2004).
  Article CAS PubMed Google Scholar
• Mongiat, M. et al. The protein core of the proteoglycan perlecan binds specifically to fibroblast growth factor-7. J. Biol. Chem. 275, 7095–7100 (2000).
  Article CAS PubMed Google Scholar
• Göhring, W., Sasaki, T., Heldin, C. H. & Timpl, R. Mapping of the binding of platelet-derived growth factor to distinct domains of the basement membrane proteins BM-40 and perlecan and distinction from the BM-40 collagen-binding epitope. Eur. J. Biochem. 255, 60–66 (1998).
  Article PubMed Google Scholar
• Hopf, M., Göhring, W., Kohfeldt, E., Yamada, Y. & Timpl, R. Recombinant domain IV of perlecan binds to nidogens, laminin–nidogen complex, fibronectin, fibulin-2 and heparin. Eur. J. Biochem. 259, 917–925 (1999).
  Article CAS PubMed Google Scholar
• Brown, J. C., Sasaki, T., Göhring, W., Yamada, E. & Timpl, R. The C-terminal domain V of perlecan promotes β1 integrin-mediated cell adhesion, binds heparin, nidogen and fibulin-2 and can be modified by glycosaminoglycans. Eur. J. Biochem. 250, 39–46 (1997).
  Article CAS PubMed Google Scholar
• Talts, J. F., Andac, Z., Göhring, W., Brancaccio, A. & Timpl, R. Binding of the G domains of laminin α1 and α2 chains and perlecan to heparin, sulfatides, α-dystroglycan and several extracellular matrix proteins. EMBO J. 18, 863–870 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Mongiat, M. et al. Perlecan protein core interacts with extracellular matrix protein 1 (ECM1), a glycoprotein involved in bone formation and angiogenesis. J. Biol. Chem. 278, 17491–17499 (2003).
  Article CAS PubMed Google Scholar
• Gonzalez, E. M., Mongiat, M., Slater, S. J., Baffa, R. & Iozzo, R. V. A novel interaction between perlecan protein core and progranulin: Potential effects on tumor growth. J. Biol. Chem. 278, 38113–38116 (2003).
  Article CAS PubMed Google Scholar